BusinessBiotricity Achieves FDA 510(k) Clearance for its Bioflux DeviceBy Nasdaq OMXDec 18, 2017, 1:01 PM UTC
BusinessBiotricity Files for its Second and Final FDA 510(k) to Bring Bioflux Solution to MarketBy Nasdaq OMXApr 12, 2017, 12:00 PM UTC
BusinessRenowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of AdvisorsBy Nasdaq OMXNov 1, 2016, 12:00 PM UTC
Businessbiotricity Receives an FDA 510(k) Clearance – Marks Major Milestone in Path to CommercializationBy Nasdaq OMXOct 18, 2016, 12:01 PM UTC
Businessbiotricity Receives an FDA 510(k) Clearance – Marks Major Milestone in Path to CommercializationBy Nasdaq OMXOct 18, 2016, 12:01 PM UTC